Evidence map›Paper›PMID 34272424›Full record

ArticleScientific reports2021

Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis.

Pedro Rodríguez-Jiménez, Lola Fernández-Messina, María C Ovejero-Benito, Pablo Chicharro, Paula Vera-Tomé, Alicia Vara, Danay Cibrian, Pedro Martínez-Fleta, María Jiménez-Fernández, Inés Sánchez-García and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. OCA-B/Pou2af1 is sufficient to promote CD4Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Deletion ofInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Pedro Rodríguez-Jiménez *Department of Dermatology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Lola Fernández-Messina *Department of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
María C Ovejero-BenitoClinical Pharmacology Department, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Pablo ChicharroDepartment of Dermatology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Paula Vera-ToméDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
Alicia VaraDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
Danay CibrianCentro Nacional de Investigaciones Cardiovasculares, CNIC, Instituto de Salud Carlos III, Madrid, Spain.
Pedro Martínez-FletaDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
María Jiménez-FernándezDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
Inés Sánchez-GarcíaDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
Mar Llamas-VelascoDepartment of Dermatology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Francisco Abad-SantosClinical Pharmacology Department, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Francisco Sánchez-MadridDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain.
Esteban DaudenDepartment of Dermatology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain. edauden@gmail.com.
Hortensia de la FuenteDepartment of Immunology, Instituto de Investigación Sanitaria del Hospital Universitario de la Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006, Madrid, Spain. hortensia.fuente@salud.madrid.org.
Universidad Autónoma de Madrid · ESHospital Universitario de La Princesa · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interplay between T cells, dendritic cells and keratinocytes is crucial for the development and maintenance of inflammation in psoriasis. GADD45 proteins mediate DNA repair in different cells including keratinocytes. In the immune system, GADD45a and GADD45b regulate the function and activation of both T lymphocytes and dendritic cells and GADD45a links DNA repair and epigenetic regulation through its demethylase activity. Here, we analyzed the expression of GADD45a and GADD45b in the skin, dendritic cells and circulating T cells in a cohort of psoriasis patients and their regulation by inflammatory signals. Thirty patients (17 male/13 female) with plaque psoriasis and 15 controls subjects (7 male/8 female), were enrolled. Psoriasis patients exhibited a lower expression of GADD45a at the epidermis but a higher expression in dermal infiltrating T cells in lesional skin. The expression of GADD45a and GADD45b was also higher in peripheral T cells from psoriasis patients, although no differences were observed in p38 activation. The expression and methylation state of the GADD45a target UCHL1 were evaluated, revealing a hypermethylation of its promoter in lesional skin compared to controls. Furthermore, reduced levels of GADD45a correlated with a lower expression UCHL1 in lesional skin. We propose that the demethylase function of GADD45a may account for its pleiotropic effects, and the complex and heterogeneous pattern of expression observed in psoriatic disease.

Indexed as

AdultAgedAged, 80 and overAntigens, DifferentiationApoptosisCell Cycle ProteinsDendritic CellsEpigenesis, GeneticFemaleGADD45 ProteinsHumansInflammationKeratinocytesMaleMethylationMiddle AgedAntigens, DifferentiationCell Cycle ProteinsGADD45A protein, humanGADD45B protein, humanGADD45 ProteinsUbiquitin ThiolesteraseUCHL1 protein, human

Identifiers

PMID34272424
PMCPMC8285512
OpenAlexW3178812707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.